Wu TY, et al. - From 1998 to 2012, 831,314 patients with 19 pathologically proven cancers were abstracted from the Taiwan Cancer Registry to quantify the lifetime risks, life expectancies (LEs) after diagnosis, expected years of life lost (EYLL), and lifetime health care expenditures for 19 major cancers in Taiwan. For this analysis, the EYLL was calculated by subtracting the LE of each cancer cohort from that of the age- and sex-matched referents simulated from national life tables. By adding up the product of survival probability and mean cost at the corresponding duration-to-date after adjustment for the inflation to the year of 2013, the estimated lifetime cost was calculated. Five cancers with a lifetime risk exceeding 4% were colorectal, liver, lung, and prostate in males, and breast and colorectal in females. Cancers with EYLL of >10 years were: esophageal, intrahepatic bile ducts, liver, pancreas, oral, nasopharyngeal, leukemia, lung, and gallbladder, extrahepatic bile ducts and biliary tract in males, and intrahepatic bile ducts, pancreas, nasopharyngeal, lung, esophageal, leukemia, liver, gallbladder, extrahepatic bile ducts and biliary tract, ovary, and stomach in females.